fingolimod hydrochloride has been researched along with Ectopic Lymph Nodes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, D; Chen, W; Cheng, Y; Dai, W; Fan, L; Ge, S; Guo, K; Li, M; Li, Y; Liu, L; Liu, T; Luo, R; Pei, G; Wang, Z; Xu, G; Xu, Y; Yao, Y; Zhang, C; Zhang, N; Zuo, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Ectopic Lymph Nodes
| Article | Year |
|---|---|
Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A.
Topics: Adult; Animals; Disease Progression; Female; Fingolimod Hydrochloride; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Interleukin-17; Kidney; Lupus Nephritis; Male; Mice; Mice, Knockout; Middle Aged; Nephrosis, Lipoid; Renal Insufficiency, Chronic; Tertiary Lymphoid Structures | 2021 |